1. This meeting is intended for non-US journalists only
Press briefing
Monday 12 June, PDT
We welcome you to the Novo Nordisk press briefing at the 77th Scientific Sessions of the American Diabetes Association (ADA) on Monday 12 June at 18.30, in the Marriot Marquis hotel.
Come to hear the latest news from the Tresiba® DEVOTE cardiovascular outcomes trial and perspectives on the Victoza® LEADER trial. There will be opportunities for Q&A and 1:1 interviews with leading global key opinion leaders, as well as Novo Nordisk spokespeople.
For more information or to RSVP, please contact: Åsa Josefsson,
NANCY JOHNSON US
Nancy has type 2 diabetes
NANCY JOHNSON US
Nancy has type 2 diabetes
This meeting is intended for non-US journalists only

2. This meeting is intended for non-US journalists only
agenda
18.30–18.45
Overview of Novo Nordisk data presented at ADA and pipeline – Mads Krogsgaard Thomsen, EVP and CSO, Novo Nordisk
18.45–18.50
Patient perspective
18.50–19.05
News from the DEVOTE trial – Bernard Zinman MD, Director, Leadership Sinai Centre for Diabetes; Senior Scientist, Lunenfeld-Tanenbaum Research Institute; Professor of Medicine, University of Toronto
19.05–19.20
What did we learn from LEADER? – Steven P. Marso, chief medical officer for HCA Midwest Health cardiovascular services; Mads Krogsgaard Thomsen, EVP and CSO, Novo Nordisk
19.30–20.00
1:1 interview opportunities
18.15–18.30
Registration and refreshments
19.20–19.30
Q&A and close
For journalist registration at the ADA 2017 scientific sessions please visit:
Media registration is free for accredited journalists. Media are asked to submit their registration request and send (via ) their valid press credentials no later than June 1, 2017.
Further information regarding registration, regulations, embargo policies and interviews at ADA can also be found via the link above.
The meeting location is just five minutes walk from the San Diego Convention Center (see map).
Meeting location:
Marriott Marquis San Diego Marina Hotel
La Costa room, level four
333 West Harbor Drive
This meeting is intended for non-US journalists only